FAQ Library

FAQ Library published on August 9, 2016
Dr. Smith discusses the genetic mutations that can occur over the course of MDS, some of which are associated with poorer outcomes, such as the transition to AML.
FAQ Library published on July 26, 2016
Keeping patients on their MDS treatment for as long as possible is critical. Dr. Smith discusses several key approaches clinicians can use to increase compliance and longevity of therapy.
FAQ Library published on June 8, 2016
In this frequently asked question, Dr. Doug Smith discusses how molecular markers such as TP53 are changing how we treat MDS.
FAQ Library published on May 12, 2016
Join Dr. Hetty Carraway as she describes how to effectively address the option of active therapy with a patient who only wants supportive care.
FAQ Library published on May 5, 2016
There are two major studies that are exploring immunotherapy for MDS and both have had consistent results.
FAQ Library published on May 5, 2016
Once you understand the knowledge your patient has, you can then begin to explain the seriousness of the individual situation.
FAQ Library published on May 5, 2016
Genetic profiles are impacting responses to agents. If you have any additional molecular abnormalities, in the MDS setting, it upstages you approximately one risk level in the IPSS.
FAQ Library published on May 5, 2016
Dr. Sekeres explains the improvements in the revised IPSS, saying it is more accurate and has been validated in patients who receive therapies for their MDS.
FAQ Library published on May 5, 2016
Using the formal frailty index does help in making decisions concerning therapy, but Dr. Sekeres is always cautious not to undertreat a patient just because of age.
FAQ Library published on May 5, 2016
Dr. Sekeres explains the odds your patient will have in responding to ESAs based on EPO and TPO levels, in addition to blood transfusions.
Page 3 of 7
Results 21 - 30 of 66

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2018 MediCom Worldwide, Inc. All rights reserved